Management of Blood Glucose in Diabetic Patients on Levothyroxine Therapy

Patient Monitoring and Assessment

Patients should self-monitor blood glucose levels closely during the first 3-4 weeks after initiating levothyroxine therapy and after any dose adjustments, as recommended by the American College of Cardiology 1, 2
Consider using continuous glucose monitoring (CGM) for patients at high risk of hypoglycemia, especially those on insulin therapy, according to Metabolism: Clinical and Experimental 3
Patients should be asked about hypoglycemic episodes at every visit to identify patterns and adjust therapy accordingly, as suggested by Metabolism: Clinical and Experimental 3

For patients taking insulin or insulin secretagogues, consider reducing sulfonylurea or glinide dose by 50% and total daily insulin dose by approximately 20% when starting levothyroxine, as recommended by the American College of Cardiology 1, 2, 4
Dose adjustments require individualization based on blood glucose monitoring results, according to the American College of Cardiology 1
Complex insulin regimens or "brittle" diabetes should be managed in coordination with the patient's diabetes care provider, as suggested by the American College of Cardiology 1, 2

Educate patients about hypoglycemia symptoms and proper management, including carrying fast-acting carbohydrates for treating hypoglycemia, as recommended by Diabetes/Metabolism Research and Reviews and Diabetes Care 5, 6, 7
Advise patients that pure glucose is the preferred treatment for hypoglycemia and that protein-containing carbohydrate sources should not be used, according to Diabetes Care 7

Patients at higher risk for hypoglycemia when taking levothyroxine include elderly patients, those with long duration of diabetes, chronic kidney disease, hypoglycemia unawareness, and complex insulin regimens, as identified by Metabolism: Clinical and Experimental and American Journal of Kidney Diseases 3, 5, 8
These patients require closer monitoring and individualized care to prevent hypoglycemia, as suggested by Metabolism: Clinical and Experimental 3

Consider prescribing glucagon for patients on insulin therapy and educate family members on glucagon administration for severe hypoglycemic events, as recommended by Metabolism: Clinical and Experimental and Diabetes Care 3, 7
Patients should carry emergency diabetes identification, as suggested by Diabetes/Metabolism Research and Reviews 6